|
|
|
Volumn 24, Issue 4 SUPPL. 11, 1997, Pages
|
|
Current status and future directions of platinum/paclitaxel-based chemotherapy of ovarian cancer
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CARBOPLATIN;
CIMETIDINE;
CISPLATIN;
CYCLOPHOSPHAMIDE;
DEXAMETHASONE;
DIPHENHYDRAMINE;
FAMOTIDINE;
PACLITAXEL;
RANITIDINE;
CANCER COMBINATION CHEMOTHERAPY;
CANCER GROWTH;
CLINICAL TRIAL;
CONFERENCE PAPER;
DRUG EFFICACY;
FEMALE;
HUMAN;
HUMAN CELL;
HUMAN TISSUE;
HYPERSENSITIVITY REACTION;
MAJOR CLINICAL STUDY;
META ANALYSIS;
NEUROTOXICITY;
OVARY CANCER;
PRIORITY JOURNAL;
SURVIVAL TIME;
TREATMENT OUTCOME;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CARBOPLATIN;
CISPLATIN;
CLINICAL TRIALS;
FEMALE;
HUMANS;
OVARIAN NEOPLASMS;
PACLITAXEL;
|
|
EID: 17444444454
PISSN: 00937754
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
|
Times cited : (10)
|
|
References (17)
|
